VIZZIA Technologies' clinical workflow optimization solution installed at FCS Tampa Cancer Center

VIZZIA Technologies, a leading provider of process and technology solutions, announced today that its clinical workflow optimization solution was recently installed at Florida Cancer Specialists & Research Institute's (FCS) Tampa Cancer Center location. The newly constructed 35,990 square foot flagship facility offers a "one-stop" approach to patient care that includes medical oncology, advanced radiation oncology technology and radiological services for identifying and diagnosing tumors. The VIZZIA solution, which leverages CenTrak's Clinical-Grade RTLS™, is designed to transform the outpatient experience and help in optimizing patient flow processes. Shortening patient wait times, ensuring patient safety and satisfaction, as well as increasing the cancer center's patient treatment capacity are among the benefits of the new solution.

"Cancer treatment can be a daunting challenge for many of our patients. We are proud to have installed the latest technologies to enhance our patients' experiences at our center. VIZZIA's advanced workflow solution allows us the visibility and data we need to accelerate the overall treatment process, so our patients can more quickly return to their normal routines," said Todd Schonherz, Florida Cancer Specialists' chief operating officer.

VIZZIA integrated its web-based information portal with the CenTrak Clinical-Grade Locating™ infrastructure. Their VIZZION Suite™ software automatically updates the location of patients and staff from CenTrak's RTLS and incorporates important workflow rules and alerts to ensure that patients move through the treatment process as efficiently as possible. The Clinical-Grade RTLS platform uses battery-operated Gen2IR™ and Virtual Wall™ devices to deliver unmatched room-, bed-, and bay-level accuracy. The advanced technology delivers rapid location update speeds and offers small, full featured tags with extremely long battery life.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Dual-responsive nanodelivery system enhances immunotherapy efficacy in metastatic bladder cancer